Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial - Harbeck, Nadia; Ciruelos, Eva; Jerusalem, Guy; Müller, Volkmar; Niikura, Naoki; Viale, Giuseppe; Bartsch, Rupert; Kurzeder, Christian; Higgins, Michaela J.; Connolly, Roisin M.; Baron-Hay, Sally; Gión, María; et al. (Nature medicine, 2024)
Online veröffentlicht: 13. September 2024